John W. Smith
185 works · 8,883 citations · h-index 47
Top works
- Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma
- A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
- Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies
- PREVENTION OF VARICELLA IN HIGH RISK CHILDREN: A COLLABORATIVE STUDY
- Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
- Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- Adjuvant multiple drug chemotherapy for osteosarcoma of the extremity
- Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized Trial
- Interleukin 1α Increases Serum Leptin Concentrations in Humans
- Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- Detection of a small virus in a cultivated human Wilms' tumor
- Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.
- Mesoaortic compression of the left renal vein (the so-called nutcracker syndrome): Repair by a new stenting procedure
- Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment.
- A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.
- Computed tomography of lower extremity tumors
- Current therapy for cutaneous melanoma
- Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group
- The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies.
- Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer